Ledger.Open graph →
SEC Form D · filed February 16, 2021

Phio Pharmaceuticals Corp

Offering
$24.3M
Sold
$14.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MARLBOROUGH, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Robert A. Ferrara · Marlborough, MADirectorCurtis A. Lockshin · Marlborough, MADirectorGerrit Dispersyn · Marlborough, MAExec · DirectorCaitlin Kontulis · Marlborough, MAExecGeert Cauwenbergh · Marlborough, MADirectorJonathan P. Freeman · Marlborough, MADirectorRobert J. Bitterman · Marlborough, MADirectorDavid Scheer · New Haven, CTDirectorMark Murray · Dallas, TXExec · DirectorPhilip Braner · Dallas, TXDirectorNeil Desai · Dallas, TXExecBrinda Ganguly · Seattle, WADirectorHarlan Krumholz · New Haven, CTDirectorGibran Mahmud · Dallas, TXDirectorH P. Dorman · Marlborough, MADirectorJohn B. Fitzgibbons · New York, NYDirectorAnish K. Bahl · New York, NYExecTasabbur C. Hasan · New York, NYDirectorVishesh Rajaram · Chennai, K7Exec · DirectorTremayne A. Williams · Morrow, GADirectorBeverly Rubin · El Segundo, CADirectorGianna H. Figaro-Sterling · Charlotte, NCDirectorH P. Dorman · Marlborough, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗